Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137


Comparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer.

Jung EJ, Kim IS, Lee EY, Kang JE, Lee SM, Kim DC, Kim JY, Park ST.

Ann Lab Med. 2013 Nov;33(6):431-40. doi: 10.3343/alm.2013.33.6.431. Epub 2013 Oct 17.


Methylation profiles in breast cancer.

Buyru N, Altinisik J, Ozdemir F, Demokan S, Dalay N.

Cancer Invest. 2009 Mar;27(3):307-12. doi: 10.1080/07357900802350814.


Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.

Kornegoor R, Moelans CB, Verschuur-Maes AH, Hogenes MCh, de Bruin PC, Oudejans JJ, van Diest PJ.

Breast Cancer Res. 2012 Jul 5;14(4):R101. doi: 10.1186/bcr3220.


Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.

Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B.

Clin Cancer Res. 2005 Mar 15;11(6):2156-62.


Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.

Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD.

World J Gastroenterol. 2004 Dec 1;10(23):3441-54.


Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.

Wang Y, Zhang D, Zheng W, Luo J, Bai Y, Lu Z.

Cancer. 2008 Mar 15;112(6):1325-36. doi: 10.1002/cncr.23312.


Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.

Verschuur-Maes AH, de Bruin PC, van Diest PJ.

Breast Cancer Res Treat. 2012 Dec;136(3):705-15. doi: 10.1007/s10549-012-2301-4. Epub 2012 Oct 27.


Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.


Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.

Asiaf A, Ahmad ST, Malik AA, Aziz SA, Rasool Z, Masood A, Zargar MA.

Tumour Biol. 2015 Aug;36(8):6485-96. doi: 10.1007/s13277-015-3339-9. Epub 2015 Mar 29.


Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.

Pirouzpanah S, Taleban FA, Mehdipour P, Atri M.

J Mol Med (Berl). 2015 Aug;93(8):917-34. doi: 10.1007/s00109-015-1268-0. Epub 2015 Mar 25.


Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.

Sharma G, Mirza S, Yang YH, Parshad R, Hazrah P, Datta Gupta S, Ralhan R.

Cell Oncol. 2009;31(6):487-500. doi: 10.3233/CLO-2009-0507.


Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients.

Van der Auwera I, Bovie C, Svensson C, Trinh XB, Limame R, van Dam P, van Laere SJ, van Marck EA, Dirix LY, Vermeulen PB.

BMC Cancer. 2010 Mar 12;10:97. doi: 10.1186/1471-2407-10-97.


Methylation signature of lymph node metastases in breast cancer patients.

Barekati Z, Radpour R, Lu Q, Bitzer J, Zheng H, Toniolo P, Lenner P, Zhong XY.

BMC Cancer. 2012 Jun 13;12:244. doi: 10.1186/1471-2407-12-244.


Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.

Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, Chen J, Zhang L, Wu M, Zhen S, Zhu J.

BMC Cancer. 2002 Nov 15;2:29. Epub 2002 Nov 15.


Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers.

Feng W, Orlandi R, Zhao N, Carcangiu ML, Tagliabue E, Xu J, Bast RC Jr, Yu Y.

BMC Cancer. 2010 Jul 20;10:378. doi: 10.1186/1471-2407-10-378.


Methylation of tumor suppressor genes in ovarian cancer.

Ozdemir F, Altinisik J, Karateke A, Coksuer H, Buyru N.

Exp Ther Med. 2012 Dec;4(6):1092-1096. Epub 2012 Sep 18.


Promoter hypermethylation profiling of distant breast cancer metastases.

Schrijver WA, Jiwa LS, van Diest PJ, Moelans CB.

Breast Cancer Res Treat. 2015 May;151(1):41-55. doi: 10.1007/s10549-015-3362-y. Epub 2015 Apr 5.


Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.

Rauscher GH, Kresovich JK, Poulin M, Yan L, Macias V, Mahmoud AM, Al-Alem U, Kajdacsy-Balla A, Wiley EL, Tonetti D, Ehrlich M.

BMC Cancer. 2015 Oct 29;15:816. doi: 10.1186/s12885-015-1777-9.

Supplemental Content

Support Center